Delivery Order SPE2DB20D2104-SPE2DB24FT74F
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,388.60, is for the delivery of 4,566,414,295 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. This is a firm-fixed-price delivery order contract with a completion date of November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,564,359,614 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,438.37 and a performance period ending on April 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,565,505,318 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract, valued at $18,726.20, is a firm fixed-price delivery order with an ultimate completion date of August 20, 2024. Amerisourcebergen, through its Corporate Office Division, will supply this critical vaccine to support the healthcare needs of military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The contract, valued at $29,762.70, is a delivery order for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The contract is a firm fixed-price agreement with a completion date of May 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,312.11 firm-fixed-price contract is for the supply of 4,565,364,928 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The award has an ultimate completion date of August 7, 2024. AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and civilian...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for 4,565,393,908 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine and has a firm fixed price of $2,922.98. The award has an ultimate completion date of August 9, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply critical medical commodities...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,089,219 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The $15,638.09 contract has a performance period through March 27, 2024 and does not include any set-aside designations. AmerisourceBergen Drug Corp also holds an indefinite delivery contract with the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,564,430 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10 ML vaccine. The contract has a ceiling value of $9,363.20 and is a firm fixed-price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,485,940 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The $12,717.66 firm fixed price contract has a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,122.52 firm fixed-price delivery order is for the supply of 4,564,893,507 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The contract has an ultimate completion date of June 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive...